Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03757533 · ClinicalTrials.gov registry record · NA
Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease
A NA study of Inflammatory Bowel Diseases, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT03757533 is a NA study of Inflammatory Bowel Diseases that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 43 participants, below the 42,261-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03757533, a NA study of Inflammatory Bowel Diseases, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Inflammatory bowel disease (IBD) including Crohn's disease (CD) and Ulcerative colitis (UC) is a chronic idiopathic intestinal disorder involving the interplay of environmental, immunomodulatory and genetic causative factors. Treatment for IBD is multimodal and includes lifestyle modification, chronic pharmacotherapy and surgery. Given the need for chronic pharmacotherapy, medication adherence is a crucial therapeutic goal in the management of IBD. In fact, medication non-adherence has been associated with greater risk of relapse and increased healthcare costs. In a previous study, the investigators found clinically identifiable risk factors for non-adherence for self-injectable biologic medications in a population with moderate to severe CD. These risk factors included smoking, prior biologic use, psychiatric history, and current narcotic use. The primary objective of this study is to use a multidisciplinary team approach that implements a targeted coaching intervention to promote behavioral change and improve medication adherence in adult patients with IBD who are at high risk of non-adherence.
Conditions Studied
Interventions
- BEHAVIORAL Health Coaching
- OTHER Surveys
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center Inflammatory Bowel Disease Clinic - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-06-11 |
| Est. Completion | 2023-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03757533
The ClinicalTrials.gov registry entry for NCT03757533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 42,261-participant average among 48 other Inflammatory Bowel Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammatory Bowel Diseases appearing as the primary indexed condition, and to 2 interventions - of which Health Coaching is the first listed.
NCT03757533 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT03757533 about?
NCT03757533 is a clinical study titled "Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease". Inflammatory bowel disease (IBD) including Crohn's disease (CD) and Ulcerative colitis (UC) is a chronic idiopathic intestinal disorder involving the interplay of environmental, immunomodulatory and genetic causative factors. Treatment for IBD is multimodal and includes lifestyle modification, chron...
What is the current status of trial NCT03757533?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2019-06-11. Estimated completion is 2023-07-21.
What conditions does trial NCT03757533 study?
This clinical trial studies the following conditions: Inflammatory Bowel Diseases.
What interventions are being tested in trial NCT03757533?
The interventions under investigation include: Health Coaching (BEHAVIORAL), Surveys (OTHER).
Who is sponsoring clinical trial NCT03757533?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03757533 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
RECRUITING · NA
-
Feasibility Test of Action Planning in Pediatric IBD
RECRUITING · NA
-
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
RECRUITING · NA
-
Fermented Food-Supplemented Diet in Ulcerative Colitis
RECRUITING · NA
-
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
RECRUITING · NA
-
BOOM-IBD2 Pivotal Clinical Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.